Tilfrinib is a potent and selective breast tumor kinase (Brk, also known as tyrosine-protein kinase 6, PTK6) inhibitor (IC50 = 3.15 nM). Exhibits >1000-fold selectivity for Brk over a panel of other kinases. Inhibits proliferation of breast cancer cells in vitro.
- Nom chimique ou matériau
- 3-(9H-Pyrido[2,3-b]indol-4-ylamino)phenol
- CAS
- 1600515-49-8
- Quantité
- 10 mg
- Cible
- Other Kinase Inhibitors
- Formule moléculaire
- C17H13N3O
- Poids de la formule
- 275.3
- Pureté
- >98%
